Avtozma - direct healthcare professional communication (DHPC)

tocilizumab

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Avtozma 20 mg/mL concentrate for solution for infusion: incorrect strength stated on peel-off vial label for specific batches

Dissemination date: 03/04/2026

Key facts

• Medicine name:
  Avtozma
• Active substance:
  tocilizumab
• Therapeutic area (MeSH):
  • Arthritis, Rheumatoid
  • Arthritis, Juvenile Rheumatoid
  • Cytokine Release Syndrome
  • COVID-19 virus infection
• DHPC type:
  • Medication error
  • Quality defect
• Human ATC codes:
  L04AC07
• Dissemination date:
  03/04/2026